Introduction: persistent high-risk HPV (hrHPV) infection is higher among women living with HIV/AIDS thus increasing their risk for cervical cancer.
Introduction
Human papilloma virus (HPV) is the most common sexually transmitted pathogen in humans and has been implicated in the aetiology of cervical, oropharyngeal and other anogenital cancers [1, 2] . More than 100 HPV genotypes have been characterized and classified based on their oncogenic potential into high-risk HPV (hrHPV) and low-risk HPV (lrHPV) genotypes [1, 3, 4] . Persistent high risk HPV infection is necessary but requires additional co-factors to cause both malignant and premalignant cervical lesions [1] . The immunosuppressive state induced by Human Immunodeficiency Virus (HIV) potentially increases HPV acquisition, persistence, and development of cervical cancer [2] . Globally, an increased risk of HPV infection and cervical squamous intraepithelial lesions (SIL) has been reported among HIV-positive women [2, [5] [6] [7] . Previous studies among HIV-positive women have reported increased multiple infections with varied hrHPV genotypes [1, 2, 8] . Although cancer of the uterine cervix is the commonest genital tract malignancy in Northern Nigeria, only a few studies have reported the prevalence of type-specific HPV among HIV-infected women [9, 10] . We have previously reported a high burden of HPV 16 and 18 and their association with malignant/premalignant cervical lesions among non HIV-infected women in Northern Nigeria. In the present study, we determined the prevalence of hrHPV and levels of CD4+T counts among HIV-positive women attending the Federal Medical Centre (FMC) Keffi and also evaluated the association between both factors and presence of cervical premalignant lesions.
Methods

Study area and population
The study was carried out at the antiretroviral clinic of Federal Medical 
Papanicolaou smear
Cervical smears obtained from each participant was stained using the standard papanicolaou's method in order to assess the presence of cervical premalignant/malignant lesions which was rated according to the 2001 Bethesda system of classification by a cytopathologist.
DNA extraction
HPV testing was done at the DNA Labs, Kaduna, Nigeria. Gel extraction prior to DNA purification for sequencing was done using QIAquick Gel Extraction Kit (QIAGEN Sample & Assay Technologies, Germany). Briefly, HPV DNA was extracted from exfoliated cervical cells using proteinase K-based digestion protocol. Cells were incubated with proteinase K solution (100 µg/ml) for three hours at 55°C. DNA was then further purified by spin column chromatography.
Detection and typing of HPV
The extracted DNA was amplified for HPV using a nested PCR approach with GP5+/GP6+( [GP5 + 5¹-TTT GTT ACT GTG GTA GAT 
Data analysis
Descriptive and inferential statistical analysis of the data was done using the statistical package for social sciences (SPSS) version 20
(SPSS Inc, Illinois, USA) for analysis after validation. Categorical variables were summarized as proportions and further analyzed using
Chi square test to assess significance of association between the variables. Logistic regression analysis was done between CD4+T count and cervical premalignant lesions and relationship expressed in odd ratio (OR). were unemployed and were housewives, while 66 (30%) were selfemployed and the remaining 33 (15%) were employed either in the public or private sector. Majority of the participants 215 (97.7%) were already on HAART while the others were treatment naive.
Results
Socio-demographic characteristics
Analysis of HPV Infection
Overall, HPV DNA was detected in 119 (54.1%) of the participants while high-risk HPV types were detected in 79 (35.9%) samples. In the present study, the risk of cervical precancerous lesions was higher in patients with lower CD4+T counts and there was a statistical significant association between CD4+T and cervical precancerous  The study therefore justified the need for routine targeted screening and treatment of HIV-infected women to reduce morbidity and mortality from cervical cancer.
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